Cargando…

Overexpression of GATA1 Confers Resistance to Chemotherapy in Acute Megakaryocytic Leukemia

It has been previously shown that acute myeloid leukemia (AML) patients with higher levels of GATA1 expression have poorer outcomes. Furthermore, pediatric Down syndrome (DS) patients with acute megakaryocytic leukemia (AMKL), whose blast cells almost universally harbor somatic mutations in exon 2 o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caldwell, John Timothy, Edwards, Holly, Dombkowski, Alan A., Buck, Steven A., Matherly, Larry H., Ge, Yubin, Taub, Jeffrey W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707876/ https://www.ncbi.nlm.nih.gov/pubmed/23874683 http://dx.doi.org/10.1371/journal.pone.0068601

Ejemplares similares

A Unique Role of GATA1s in Down Syndrome Acute Megakaryocytic Leukemia Biology and Therapy
por: Xavier, Ana C., et al.
Publicado: (2011)

Gene Signature of High White Blood Cell Count in B-Precursor Acute Lymphoblastic Leukemia
por: Edwards, Holly, et al.
Publicado: (2016)

Evaluating venetoclax and its potential in treatment-naïve acute myeloid leukemia
por: Knight, Tristan, et al.
Publicado: (2019)

Acute Myeloid Leukemia Cells Harboring MLL Fusion Genes or with the Acute Promyelocytic Leukemia Phenotype Are Sensitive to the Bcl-2-selective Inhibitor ABT-199
por: Niu, Xiaojia, et al.
Publicado: (2014)

Panobinostat Synergistically Enhances the Cytotoxic Effects of Cisplatin, Doxorubicin or Etoposide on High-Risk Neuroblastoma Cells
por: Wang, Guan, et al.
Publicado: (2013)

CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells
por: Qi, Wenxiu, et al.
Publicado: (2014)

The leukemia associated ETO nuclear repressor gene is regulated by the GATA-1 transcription factor in erythroid/megakaryocytic cells
por: Ajore, Ram, et al.
Publicado: (2010)

Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model
por: Arkoun, Brahim, et al.
Publicado: (2022)

Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay
por: Juban, Gaëtan, et al.
Publicado: (2020)

“FLipping” the Story: FLT3-Mutated Acute Myeloid Leukemia and the Evolving Role of FLT3 Inhibitors
por: Knight, Tristan E., et al.
Publicado: (2022)

Repercussion of Megakaryocyte-Specific Gata1 Loss on Megakaryopoiesis and the Hematopoietic Precursor Compartment
por: Meinders, Marjolein, et al.
Publicado: (2016)

GATA1-defective immune-megakaryocytes as possible drivers of idiopathic pulmonary fibrosis
por: Gobbo, Francesca, et al.
Publicado: (2023)

Congenital acute megakaryocytic leukemia
por: Mathur, N. B., et al.
Publicado: (2011)

Is it primary myelofibrosis or chronic megakaryocytic leukemia?
por: Lichtman, Marshall A.
Publicado: (2022)

Histone deacetylases 1 and 2 cooperate in regulating BRCA1, CHK1, and RAD51 expression in acute myeloid leukemia cells
por: Zhao, Jianyun, et al.
Publicado: (2016)

FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors
por: Mancini, Elena, et al.
Publicado: (2012)

Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51
por: Xie, Chengzhi, et al.
Publicado: (2013)

Inhibition of Histone Deacetylases 1 and 6 Enhances Cytarabine-Induced Apoptosis in Pediatric Acute Myeloid Leukemia Cells
por: Xu, Xuelian, et al.
Publicado: (2011)

The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T- cell acute lymphoblastic leukemia: A report from the Children's Oncology Group
por: Gedman, Amanda Larson, et al.
Publicado: (2009)

Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia
por: Kuusanmäki, Heikki, et al.
Publicado: (2023)

Monozygotic twins with neuroblastoma MS have a similar molecular profile: a case of twin-to-twin metastasis
por: Shatara, Margaret, et al.
Publicado: (2019)

Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy
por: Carter, Jenna L., et al.
Publicado: (2020)

PSTPIP2 dysregulation contributes to aberrant terminal differentiation in GATA-1-deficient megakaryocytes by activating LYN
por: Liu, L, et al.
Publicado: (2014)

GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy
por: Yang, Li, et al.
Publicado: (2017)

GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1
por: Singh, Preeti, et al.
Publicado: (2021)

Inhibition of GATA2 restrains cell proliferation and enhances apoptosis and chemotherapy mediated apoptosis in human GATA2 overexpressing AML cells
por: Menendez-Gonzalez, Juan Bautista, et al.
Publicado: (2019)

Exposure of Larval Zebrafish to the Insecticide Propoxur Induced Developmental Delays that Correlate with Behavioral Abnormalities and Altered Expression of hspb9 and hspb11
por: Shields, Jeremiah N., et al.
Publicado: (2019)

Overexpression of MN1 Confers Resistance to Chemotherapy, Accelerates Leukemia Onset, and Suppresses p53 and Bim Induction
por: Pardee, Timothy S.
Publicado: (2012)

MAP4K1 expression is a novel resistance mechanism and independent prognostic marker in AML-but can be overcome via targeted inhibition
por: Knight, Tristan E., et al.
Publicado: (2021)

Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia
por: Luedtke, Daniel A., et al.
Publicado: (2020)

Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells
por: Zhao, Jianyun, et al.
Publicado: (2016)

Correction: GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy
por: Yang, Li, et al.
Publicado: (2017)

hGATA1 Under the Control of a μLCR/β-Globin Promoter Rescues the Erythroid but Not the Megakaryocytic Phenotype Induced by the Gata1 ( low ) Mutation in Mice
por: Martelli, Fabrizio, et al.
Publicado: (2021)

Phytosphingosine promotes megakaryocytic differentiation of myeloid leukemia cells
por: Han, Sang Hee, et al.
Publicado: (2015)

Clinical diagnosis of adult patients with acute megakaryocytic leukemia
por: Zhao, Guangjie, et al.
Publicado: (2018)

Simultaneous cotargeting of ATR and RNA Polymerase I transcription demonstrates synergistic antileukemic effects on acute myeloid leukemia
por: Wang, Tingting, et al.
Publicado: (2019)

Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells
por: Luedtke, Daniel A, et al.
Publicado: (2017)

Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with GATA1 mutation
por: Nishinaka-Arai, Yoko, et al.
Publicado: (2020)

SON inhibits megakaryocytic differentiation via repressing RUNX1 and the megakaryocytic gene expression program in acute megakaryoblastic leukemia
por: Vukadin, Lana, et al.
Publicado: (2020)

Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity of Gilteritinib and MRX-2843 in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia
por: Wu, Shuangshuang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fne3mn2ikq6to16d6gqdrh2rv0